Patents by Inventor Enas Halumi

Enas Halumi has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20250019441
    Abstract: The present invention relates to treatment of cancer using an anti-human ILT2 monoclonal antibody. The treatment may additionally comprise pembrolizumab, optionally with chemotherapy, or cetuximab.
    Type: Application
    Filed: July 11, 2024
    Publication date: January 16, 2025
    Applicants: BIOND BIOLOGICS LTD., GENZYME CORPORATION
    Inventors: Dana Haves Ziv, Liat Tevel, Enas Halumi, Nyra Goldstein, Tsuri Peretz, Ilana Goldshtein, Tal Gabay, Anna Fridam-Dror, Itay Friedman, Sharon Hashmueli, Motti Hakim, Ilana Mandel, Avidor Shulman, Yair Sapir, Tehila Ben-Moshe, Giovanni Abbadessa, Meijing Wu, Nigel Patrick Somerville Crawford, Rui Wang, Maria Agarwal, Cecilia Deantonio, Raymond Perez, Ji Lin